These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22886791)

  • 41. 4-1BB ligand signaling to T cells limits T cell activation.
    Eun SY; Lee SW; Xu Y; Croft M
    J Immunol; 2015 Jan; 194(1):134-41. PubMed ID: 25404362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulatory role of CD8+ T lymphocytes in bone marrow eosinophilopoiesis.
    Rådinger M; Sergejeva S; Johansson AK; Malmhäll C; Bossios A; Sjöstrand M; Lee JJ; Lötvall J
    Respir Res; 2006 Jun; 7(1):83. PubMed ID: 16740158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: comparison with B7.1 and 4-1BBL.
    Serghides L; Bukczynski J; Wen T; Wang C; Routy JP; Boulassel MR; Sekaly RP; Ostrowski M; Bernard NF; Watts TH
    J Immunol; 2005 Nov; 175(10):6368-77. PubMed ID: 16272289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8(+) T cells.
    Humphreys IR; Lee SW; Jones M; Loewendorf A; Gostick E; Price DA; Benedict CA; Ware CF; Croft M
    Eur J Immunol; 2010 Oct; 40(10):2762-8. PubMed ID: 20722077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune regulation by 4-1BB and 4-1BBL: complexities and challenges.
    Wang C; Lin GH; McPherson AJ; Watts TH
    Immunol Rev; 2009 May; 229(1):192-215. PubMed ID: 19426223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cutting edge: priming of CD8 T cell immunity to herpes simplex virus type 1 requires cognate TLR3 expression in vivo.
    Davey GM; Wojtasiak M; Proietto AI; Carbone FR; Heath WR; Bedoui S
    J Immunol; 2010 Mar; 184(5):2243-6. PubMed ID: 20124105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
    Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB
    Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a potent melanoma vaccine capable of stimulating CD8(+) T-cells independently of dendritic cells in a mouse model.
    Powell KL; Stephens AS; Ralph SJ
    Cancer Immunol Immunother; 2015 Jul; 64(7):861-72. PubMed ID: 25893808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes.
    Sluijter BJ; van den Hout MF; Stam AG; Lougheed SM; Suhoski MM; van den Eertwegh AJ; van den Tol MP; van Leeuwen PA; Meijer S; Scheper RJ; June CH; de Gruijl TD; Santegoets SJ
    Clin Immunol; 2010 Nov; 137(2):221-33. PubMed ID: 20708974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
    Ruby CE; Redmond WL; Haley D; Weinberg AD
    Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Programmed death-1 shapes memory phenotype CD8 T cell subsets in a cell-intrinsic manner.
    Charlton JJ; Chatzidakis I; Tsoukatou D; Boumpas DT; Garinis GA; Mamalaki C
    J Immunol; 2013 Jun; 190(12):6104-14. PubMed ID: 23686498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of 4-1BBL and TRAF1 in the CD8 T cell response to influenza virus and HIV.
    Watts TH; Lin GH; Wang C; McPherson AJ; Snell LM; Sabbagh L
    Adv Exp Med Biol; 2011; 691():177-86. PubMed ID: 21153322
    [No Abstract]   [Full Text] [Related]  

  • 53. CD8 cell division maintaining cytotoxic memory occurs predominantly in the bone marrow.
    Parretta E; Cassese G; Barba P; Santoni A; Guardiola J; Di Rosa F
    J Immunol; 2005 Jun; 174(12):7654-64. PubMed ID: 15944266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antigen-bearing dendritic cells regulate the diverse pattern of memory CD8 T-cell development in different tissues.
    Shen CH; Talay O; Mahajan VS; Leskov IB; Eisen HN; Chen J
    Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22587-92. PubMed ID: 21149737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An adenoviral cancer vaccine co-encoding a tumor associated antigen together with secreted 4-1BBL leads to delayed tumor progression.
    Ragonnaud E; Andersson AM; Pedersen AE; Laursen H; Holst PJ
    Vaccine; 2016 Apr; 34(18):2147-56. PubMed ID: 27004934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrinsic 4-1BB signals are indispensable for the establishment of an influenza-specific tissue-resident memory CD8 T-cell population in the lung.
    Zhou AC; Wagar LE; Wortzman ME; Watts TH
    Mucosal Immunol; 2017 Sep; 10(5):1294-1309. PubMed ID: 28051085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 4-1BB Regulates Effector CD8 T Cell Accumulation in the Lung Tissue through a TRAF1-, mTOR-, and Antigen-Dependent Mechanism to Enhance Tissue-Resident Memory T Cell Formation during Respiratory Influenza Infection.
    Zhou AC; Batista NV; Watts TH
    J Immunol; 2019 Apr; 202(8):2482-2492. PubMed ID: 30867239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo 4-1BB deficiency in myeloid cells enhances peripheral T cell proliferation by increasing IL-15.
    Choi BK; Kim YH; Lee DG; Oh HS; Kim KH; Park SH; Lee J; Vinay DS; Kwon BS
    J Immunol; 2015 Feb; 194(4):1580-90. PubMed ID: 25601928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity.
    Kudernatsch RF; Letsch A; Guerreiro M; Löbel M; Bauer S; Volk HD; Scheibenbogen C
    Eur J Immunol; 2014 Dec; 44(12):3532-42. PubMed ID: 25231631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors.
    Sharma RK; Elpek KG; Yolcu ES; Schabowsky RH; Zhao H; Bandura-Morgan L; Shirwan H
    Cancer Res; 2009 May; 69(10):4319-26. PubMed ID: 19435920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.